Omnicell | OMCL - Sales Revenues

Stock Price
43.12
Daily Change
-0.68 -1.55%
Monthly
14.68%
Yearly
54.22%
Q2 Forecast
42.25

Omnicell reported $309.88M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AppLovin 1.84B 180M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Cardinal Health USD 60.9B 4.73B Mar/2026
Cerillion plc GBP 24.4M 3.48M Sep/2025
Computer Programs Systems USD 87.79M 3.96M Dec/2025
Healthcare Services USD 466.68M 2.34M Dec/2025
HealthStream USD 79.71M 3.24M Dec/2025
HeartBeam USD 0 0 Mar/2025
IQVIA Holdings USD 4.15B 210M Mar/2026
McKesson USD 92.3B 13.86B Mar/2026
Omnicell USD 309.88M 4.12M Mar/2026
Stanley Black & Decker USD 3.85B 150M Mar/2026
Steris USD 1.59B 90M Mar/2026
Veeva Systems USD 835.95M 24.72M Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022